Literature DB >> 29786077

Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.

Hao Liu1,2, Wei Chen1,2, Xiao Zhi1,2, En-Jiang Chen1,2, Tao Wei1,2, Jian Zhang1,2, Jian Shen1,2, Li-Qiang Hu1,2, Bin Zhao3, Xin-Hua Feng3, Xue-Li Bai1,2, Ting-Bo Liang4,5.   

Abstract

Tumor self-seeding occurs when circulating malignant cells reinfiltrate the original tumor. The process may breed more aggressive tumor cells, which may contribute to cancer progression. In this study, we observed tumor self-seeding in mouse xenograft models of hepatocellular carcinoma (HCC) for the first time. We confirmed that circulating tumor cell uptake of tumor-derived exosomes, which are increasingly recognized as key instigators of cancer progression by facilitating cell-cell communication, promoted tumor self-seeding by enhancing the invasive and migration capability of recipient HCC cells. Horizontal transfer of exosomal microRNA-25-5p to anoikis-resistant HCC cells significantly enhanced their migratory and invasive abilities, whereas inhibiting microRNA-25-5p alleviated these effects. Our experiments delineate an exosome-based novel pathway employed by functional microRNA from the original tumor cells that can influence the biological fate of circulating tumor cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29786077     DOI: 10.1038/s41388-018-0309-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

2.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).

Authors:  R M Johnstone; M Adam; J R Hammond; L Orr; C Turbide
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

3.  MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.

Authors:  B-S Li; Q-F Zuo; Y-L Zhao; B Xiao; Y Zhuang; X-H Mao; C Wu; S-M Yang; H Zeng; Q-M Zou; G Guo
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

4.  Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.

Authors:  Jung Eun Park; Hon Sen Tan; Arnab Datta; Ruenn Chai Lai; Huoming Zhang; Wei Meng; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2010-02-01       Impact factor: 5.911

5.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

6.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms.

Authors:  Yinglong Zhang; Qiong Ma; Tao Liu; Shi Ke; Kuo Jiang; Yanhua Wen; Baoan Ma; Yong Zhou; Qingyu Fan; Xiuchun Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-27       Impact factor: 4.553

9.  MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  RNA       Date:  2014-07-01       Impact factor: 4.942

10.  Exosomes released from breast cancer carcinomas stimulate cell movement.

Authors:  Dinari A Harris; Sajni H Patel; Marjan Gucek; An Hendrix; Wendy Westbroek; Justin W Taraska
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

View more
  22 in total

Review 1.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

Review 2.  Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.

Authors:  Changbiao Li; Xiao Xu
Journal:  Cell Mol Life Sci       Date:  2019-07-12       Impact factor: 9.261

Review 3.  Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).

Authors:  Shuyue Yang; Jiaxin Wang; Shidong Wang; Anni Zhou; Guiping Zhao; Peng Li
Journal:  Int J Oncol       Date:  2022-06-08       Impact factor: 5.884

4.  Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting CDKN1B.

Authors:  Xiaoduan Li; Meiling Tang
Journal:  Cancer Med       Date:  2020-06-26       Impact factor: 4.452

Review 5.  Exosomes-the enigmatic regulators of bone homeostasis.

Authors:  Minhao Gao; Weiyang Gao; J M Papadimitriou; Changqing Zhang; Junjie Gao; Minghao Zheng
Journal:  Bone Res       Date:  2018-12-07       Impact factor: 13.567

6.  The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma.

Authors:  Brynjar Mauseth; Ketil André Camilio; Jihua Shi; Clara Louise Hammarström; Øystein Rekdal; Baldur Sveinbjørnsson; Pål-Dag Line
Journal:  Mol Ther Oncolytics       Date:  2019-05-21       Impact factor: 7.200

Review 7.  Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.

Authors:  Andrei Sorop; Diana Constantinescu; Florentina Cojocaru; Anca Dinischiotu; Dana Cucu; Simona Olimpia Dima
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

8.  Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.

Authors:  Kun Zhang; Chu-Xiao Shao; Jin-de Zhu; Xin-Liang Lv; Chao-Yong Tu; Chuan Jiang; Min-Jie Shang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 9.  The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.

Authors:  Devis Pascut; Muhammad Yogi Pratama; Niem V T Vo; Rina Masadah; Claudio Tiribelli
Journal:  Cancers (Basel)       Date:  2020-03-29       Impact factor: 6.639

Review 10.  The significance of exosomes in the development and treatment of hepatocellular carcinoma.

Authors:  Xin Li; Chuanyun Li; Liping Zhang; Min Wu; Ke Cao; Feifei Jiang; Dexi Chen; Ning Li; Weihua Li
Journal:  Mol Cancer       Date:  2020-01-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.